981 results on '"Goss, Christopher H"'
Search Results
2. Symptom phenotyping in people with cystic fibrosis during acute pulmonary exacerbations using machine-learning K-means clustering analysis
3. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
4. Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force
5. Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries
6. Identification of prognostic biomarkers for antibiotic associated nephrotoxicity in cystic fibrosis
7. Computed tomography body composition and clinical outcomes following lung transplantation in cystic fibrosis
8. Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective
9. Role of hyperglycemia in cystic fibrosis pulmonary exacerbations
10. Metabolism and pharmacokinetics of vitamin D in patients with cystic fibrosis
11. Potential implicit bias in attribution of adverse events in randomized controlled trials in cystic fibrosis
12. Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation
13. Development and Internal Validation of a Prognostic Model of the Probability of Death or Lung Transplantation Within 2 Years for Patients With Cystic Fibrosis and FEV1 ≤ 50% Predicted
14. Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients
15. The lung allocation score and other available models lack predictive accuracy for post-lung transplant survival
16. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
17. Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbations
18. Low body mass index as a barrier to lung transplant in cystic fibrosis
19. A Novel Tool to Evaluate the Accuracy of Predicting Survival in Cystic Fibrosis
20. A survey of cystic fibrosis physicians' views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftor.
21. A Framework for Using Real-World Data and Health Outcomes Modeling to Evaluate Machine Learning–Based Risk Prediction Models
22. A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis
23. Health care costs related to home spirometry in the eICE randomized trial
24. Variability in azithromycin practices among lung transplant providers in the International Society for Heart and Lung Transplantation Community
25. Challenges to the optimisation of cystic fibrosis exacerbation treatment outcomes
26. 238 Equity Considerations and Impacts when Implementing Remote Technologies
27. Rates of adverse and serious adverse events in children with cystic fibrosis
28. The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis
29. Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National Registries
30. Utilization of electronic patient-reported outcome measures in cystic fibrosis research: Application to the GALAXY study
31. Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms
32. Bridging the survival gap in cystic fibrosis: An investigation of lung transplant outcomes in Canada and the United States
33. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study
34. Impact of sinus surgery in people with cystic fibrosis and chronic rhinosinusitis in the era of highly effective modulator therapy: Protocol for a prospective observational study.
35. Qualitative Analysis of Perspectives on Lung Transplant among People with Cystic Fibrosis.
36. Strong toll-like receptor responses in cystic fibrosis patients are associated with higher lung function
37. Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study
38. The future of cystic fibrosis care: a global perspective
39. A 57-Year-Old Female Presenting With Cardiopulmonary Arrest Secondary to Severe Hypokalemia From a Fanconi-Like Syndrome: A Case Report
40. The cost of simplifying treatments for cystic fibrosis: Implications of the SIMPLIFY trial
41. Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency
42. An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine
43. Effects of Air Pollution and Other Environmental Exposures on Estimates of Severe Influenza Illness, Washington, USA
44. A Dramatic Decline in Lung Transplantation for Cystic Fibrosis in the United States
45. Olfactory loss in people with cystic fibrosis: Community perceptions and impact
46. Correspondence between lung function and symptom measures from the Cystic Fibrosis Respiratory Symptom Diary–Chronic Respiratory Infection Symptom Score (CFRSD-CRISS)
47. Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis
48. Correspondence between symptoms and preference-based health status measures in the STOP study
49. Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.
50. "We'll deal with it as it comes": A qualitative analysis of romantic partners' dyadic coping in cystic fibrosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.